Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

The genomic landscape of tuberous sclerosis complex.

Martin KR, Zhou W, Bowman MJ, Shih J, Au KS, Dittenhafer-Reed KE, Sisson KA, Koeman J, Weisenberger DJ, Cottingham SL, DeRoos ST, Devinsky O, Winn ME, Cherniack AD, Shen H, Northrup H, Krueger DA, MacKeigan JP.

Nat Commun. 2017 Jun 15;8:15816. doi: 10.1038/ncomms15816.

2.

Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.

MacKeigan JP, Krueger DA.

Neuro Oncol. 2015 Dec;17(12):1550-9. doi: 10.1093/neuonc/nov152. Epub 2015 Aug 19. Review.

3.

Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors.

Ballif BA, Roux PP, Gerber SA, MacKeigan JP, Blenis J, Gygi SP.

Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):667-72. Epub 2005 Jan 12.

Supplemental Content

Loading ...
Support Center